SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
IDEX Biometrics ASA (IDBA) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 22/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IDBA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio297.40
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.07
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-0.04 |
$191.4K |
$-16.56M |
-8651.2% |
| 2015 |
$-0.06 |
$39.7K |
$-26.03M |
-65568% |
| 2016 |
$-0.04 |
$4.46M |
$-23.51M |
-527.2% |
| 2017 |
$-0.06 |
$1.95M |
$-31.11M |
-1593.2% |
| 2018 |
$-0.30 |
$250.33K |
$-30.23M |
-12076% |
| 2019 |
$-0.27 |
$158.29K |
$-32.42M |
-20482% |
| 2020 |
$-0.15 |
$1.1M |
$-26.75M |
-2442.9% |
| 2021 |
$-0.20 |
$2.84M |
$-32.55M |
-1146.1% |
| 2022 |
$-0.15 |
$4.09M |
$-32.66M |
-798.1% |
| 2023 |
$-1.07 |
$4.15M |
$-26.71M |
-643.4% |
